Technology
Cell Shuttle
Cartridge
Software
Services
IDMO Overview
IDMO Capabilities
IDMO Advantage
IDMO Smart Factories
Partnering
Existing TAP Partners
TAP Overview
Partner With Cellares
Company
Mission
Leadership
Board of Advisors
Board of Directors
Investors
Resources
Contact
Careers
Interdisciplinary Team
Cultures & Values
Perks
Opportunities
News
Partner with us
Cellares
Technology
Cell Shuttle
Cartridge
Software
Services
IDMO Overview
IDMO Capabilities
IDMO Advantage
IDMO Smart Factories
Partnering
Existing TAP Partners
TAP Overview
Partner With Cellares
Company
Mission
Leadership
Board of Advisors
Board of Directors
Investors
Resources
Contact
Careers
Interdisciplinary Team
Cultures & Values
Perks
Opportunities
News
Partner with us
January 18, 2023
As Cell Therapy Gains Ground, Efforts Emerge to Improve CAR T-Manufacturing
Related News
September 11, 2023
Cellares and Lyell to Evaluate Automated Manufacturing of Lyell’s CAR T-Cell Therapy on Cellares’ Cell Shuttle Platform
August 28, 2023
Cellares Announces Bristol Myers Squibb has Joined Technology Adoption Partnership Program to Evaluate Automated Manufacturing of CAR-T Cell Therapy on the Cell Shuttle Platform
August 23, 2023
Exclusive: Bloomberg Technology’s Ed Ludlow Interviews Cellares’ CEO and Co-founder, Fabian Gerlinghaus on Company’s Massive $255M Series C Up-Round